biomedicina slovenica


"Anastrozol" : 9

  1. Tryfonidis Konstantinos; Čufer Tanja
    A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378).
    2016
  2. Rakuša Matej; Čokolič Miro
    Obravnava bolnice z osteoporozo, s hormonsko odvisnim karcinomom dojk in z dolgotrajnim zdravljenjem z anastrozolom
    2012
  3. Piškur Peter; Sonc Monika; Čufer Tanja; Borštnar Simona; Mrhar Aleš
    Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: #a #Slovenian perspective
    2006
  4. Snoj Nataša; Drev Primož; Golouh Rastko; Čufer Tanja
    The response to treatment with anastrozole and tamoxifen in HER2 positive breast cancer patients
    2005
  5. Snoj Nataša; Drev Primož; Pajk Bojana; Borštnar Simona; Golouh Rastko; Čufer Tanja
    The response to treatment with anastrozole in HER2 positive metastatic breast cancer patients
    2004
  6. Piškur Peter; Sonc Monika; Čufer Tanja; Borštnar Simona; Mrhar Aleš
    Pharmacoeconomic aspects of adjuvant early breast cancer (EBC) treatment in postmenopausal women with anastrozole (A) or tamoxifen (T): Slovenian perspective
    2004
  7. Piškur Peter; Sonc Monika; Čufer Tanja; Borštnar Simona; Mrhar Aleš
    Pharmacoeconomic aspects of adjuvant early breast cancer (EBC) treatment in postmenopausal women with anastrozole (A) or tamoxifen (T): Slovenian perspective
    2004
  8. Drev P; Golouh R; Snoj Nataša; Čufer T
    Correlation between Her-2 status in primary tumour and response to anastrozole in patients with metastatic breast cancer
    2004
  9. Piškur P; Sonc M; Čufer T; Borštnar S; Mrhar A
    Pharmacoeconomics aspects of adjuvant early breast cancer treatment in postmenopausal women with anastrozole or tamoxifen: a Slovenian perspective
    2004



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics